Regeneron Pharmaceuticals (REGN) Share-based Compensation Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.66% |
| Dec 31, 2025 | -18.10% |
| Sep 30, 2025 | 5.29% |
| Jun 30, 2025 | 12.77% |
| Mar 31, 2025 | 11.13% |
| Dec 31, 2024 | 26.62% |
| Sep 30, 2024 | 10.40% |
| Jun 30, 2024 | 10.50% |
| Mar 31, 2024 | -3.60% |
| Dec 31, 2023 | 3.62% |
| Sep 30, 2023 | 22.61% |
| Jun 30, 2023 | 26.41% |
| Mar 31, 2023 | 43.02% |
| Dec 31, 2022 | 23.14% |
| Sep 30, 2022 | 21.48% |
| Jun 30, 2022 | 9.83% |
| Mar 31, 2022 | 27.50% |
| Dec 31, 2021 | 55.06% |
| Sep 30, 2021 | 35.28% |
| Jun 30, 2021 | 40.58% |
| Mar 31, 2021 | 23.72% |
| Dec 31, 2020 | -8.99% |
| Sep 30, 2020 | -13.58% |
| Jun 30, 2020 | -2.17% |
| Mar 31, 2020 | -1.95% |
| Dec 31, 2019 | 5.37% |
| Sep 30, 2019 | 5.02% |
| Jun 30, 2019 | -0.94% |
| Mar 31, 2019 | 30.95% |
| Dec 31, 2018 | -0.36% |
| Sep 30, 2018 | -10.87% |
| Jun 30, 2018 | -11.92% |
| Mar 31, 2018 | -38.41% |
| Dec 31, 2017 | -17.74% |
| Sep 30, 2017 | -4.78% |
| Jun 30, 2017 | -7.92% |
| Mar 31, 2017 | -5.95% |
| Dec 31, 2016 | -2.41% |
| Sep 30, 2016 | 28.05% |
| Jun 30, 2016 | 39.71% |
| Mar 31, 2016 | 37.10% |
| Dec 31, 2015 | 40.15% |
| Sep 30, 2015 | 50.66% |
| Jun 30, 2015 | 45.40% |
| Mar 31, 2015 | 36.91% |
| Dec 31, 2014 | 56.62% |
| Sep 30, 2014 | 48.87% |
| Jun 30, 2014 | 45.87% |
| Mar 31, 2014 | 42.91% |
| Dec 31, 2013 | 134.50% |
| Sep 30, 2013 | 122.76% |
| Jun 30, 2013 | 126.68% |
| Mar 31, 2013 | 128.14% |
| Dec 31, 2012 | 98.11% |
| Sep 30, 2012 | 53.66% |
| Jun 30, 2012 | 58.16% |
| Mar 31, 2012 | 57.04% |
| Dec 31, 2011 | 14.50% |
| Sep 30, 2011 | 52.04% |
| Jun 30, 2011 | 42.37% |
| Mar 31, 2011 | 67.55% |
| Dec 31, 2010 | 56.71% |
| Sep 30, 2010 | 17.08% |